Sign in to see your portfolio and net worth.
Your portfolio is private to your account. We store only a scrambled version of your password.
| Asset | Shares | Avg cost | Price | Value | Return | Today |
|---|
Johnson & Johnson's ebitda was $25.5 billion for the fiscal year ended December 2014, up 24.2% from $20.5 billion a year earlier. In fiscal 2012 it was $16.9 billion. In the most recent quarter (ended March 2015) ebitda was $6.7 billion, +0.9% from the same quarter a year earlier.
| Fiscal year | EBITDA | Change |
|---|---|---|
| 2014 | $25.5 billion | +24.2% |
| 2013 | $20.5 billion | +10.2% |
| 2012 | $18.6 billion | +10.0% |
| 2012 | $16.9 billion |
More for JNJ: Revenue · Gross profit · Operating income · Net income · Earnings per share (EPS) · Shares outstanding · Free cash flow · P/E ratio · All-time high
Source: SEC filings (10-K and 10-Q). Quarterly and trailing 12-month charts are in the interactive chart above.
AAPL · MSFT · NVDA · GOOGL · AMZN · META · TSLA · BRK-B · AVGO · LLY · JPM · V · WMT · XOM · UNH · MA · ORCL · COST · HD · PG · NFLX · BAC · ABBV